Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients.
about
Weight-based dosing in medication use: what should we know?II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.Considerations for dosing immunoglobulin in obese patients.Initial intravenous immunoglobulin doses should be based on adjusted body weight in obese patients with primary immunodeficiency disorders.Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.Clinical challenges in the management of patients with B cell immunodeficiencies.
P2860
Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutic immunoglobulin sho ...... body weight in obese patients.
@en
type
label
Therapeutic immunoglobulin sho ...... body weight in obese patients.
@en
prefLabel
Therapeutic immunoglobulin sho ...... body weight in obese patients.
@en
P2093
P2860
P356
P1476
Therapeutic immunoglobulin sho ...... body weight in obese patients.
@en
P2093
P2860
P304
P356
10.1111/CEI.12616
P577
2015-05-25T00:00:00Z